Back to Overview
Dr. Martin Fabry
Martin Fabry completed his bachelor’s degree in Molecular Biomedicine at the University of Bonn in 2014 and subsequently moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York), where he worked on improving CRISPR/Cas9 technologies. In 2016, he obtained a master’s degree in Life and Medical Sciences with a focus on molecular mechanisms of immunity, before starting his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge, where he studied genome organisation and stability.
After receiving his doctorate in 2020, Martin worked as a postdoctoral fellow in computational biology at the Gurdon Institute and the European Bioinformatics Institute (EBI) in Cambridge, focusing on stem cell development and the establishment of new technologies for stem cell differentiation.
Martin is a registered German and European Patent and Trademark Attorney, and became Managing Director of IP2 in early 2025.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
Teslas Robotaxi crashed
In the US, autonomous cabs are already an integral part of transportation, especially in cities such as San Francisco, Los Angeles and Phoenix. Waymo, an Alphabet Group company, is the leading provider in this area. Waymo currently has 1,500 robotaxis on the road and,...
First Aid
From left to right: David – Viola – Tamara – Uschi – Bernd – Simona – Martin – Dietmar – Bonnie - Vera Did you know that only 40% of the German population are able to provide first aid in an emergency? This is an astonishingly low figure when you compare it with our...
Magic Mushrooms
Are mushrooms excluded from patent protection? If a green-blue film of mold covers bread, fruit or other foodstuffs, the food is considered hazardous to health and ends up in the garbage can. In biotechnology however, molds, especially of the genus Aspergillus, are...
Back to Overview